A Phase 3 Study to Evaluate The Efficacy, Immunogenicity, and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Subunit (Vaccine)
Inscribirse For A Study
VACCINE IN ADULTS
- Healthy volunteers
- mRNA vaccine
Conquest Research needs volunteers for an RSV Vaccine trial evaluating a medication designed for the prevention of Respiratory Syncytial Virus. You may qualify if you:
Eligible participants will receive study-related care at no cost. Compensation for time and travel may be available. No medical insurance is required for participation.